Beyond physical benefits, ballroom dancing fosters strong social connections and emotional well-being. Many students at Dance ...

Investors in Elevance Health, Inc. ELV need to pay close attention to the stock based on moves in the options market lately. That is because the June 20, 2025 $270Call had some of the highest implied ...

Story and photo by Heather Robinson Hernandez As Lindsay Reeves prepared to leave home for college, someone asked her mother, “What if she misses the ...

Getting hooked on self-help books can have both positive and negative outcomes. Knowing when to break the habit of fixing ...

I was delighted recently to discover that three of my favorite authors, all from extremely different backgrounds and ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Uplift Education and Baylor Scott & White Health partnered to create the Uplift Heights Healthcare Institute, offering four ...

GreensKeeper Asset Management, an investment management company, released its fourth quarter investor letter. A copy of the ...

Elevance Health, Inc. (NYSE:ELV – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the sixteen brokerages that are currently covering the company, Marketbeat.com reports.

Humana attributes the expected slowdown to factors that won't repeat in 2025, such as the impact of the “two-midnight” rule, though it still expects high specialty drug costs. The company also noted ...

Cantor Fitzgerald reaffirmed its Neutral stance on Humana (NYSE:HUM) stock, maintaining the price target at $290.00. The stock, currently trading at $257.34, has experienced a significant 11.4% ...